ENDPOINTS

SpliceBio gets $135M shortly after starting first clinical trial

In the difficult field of gene therapies, some biotech startups are still reeling in large amounts of capital. Barcelona-based SpliceBio is the latest. The 40-employee upstart bagged a $135 million Series B to run a ...

Jun 11, 2025 - 08:10
 0
SpliceBio gets $135M shortly after starting first clinical trial
In the difficult field of gene therapies, some biotech startups are still reeling in large amounts of capital. Barcelona-based SpliceBio is the latest. The 40-employee upstart bagged a $135 million Series B to run a ...
Read More

Tags:

Previous Article

AWE Day 1: Snap announces new glasses for 2026, Qualcomm announces AR1+ chipset

Next Article

Intense weather means rethinking your home construction — and insurance

Related Posts

FDA adcomm votes unanimously against Pfizer's prostate cancer drug combo

FDA adcomm votes unanimously against Pfizer's prostate ...

May 22, 2025  0

Reality check: Unpacking the $150B GLP-1 market forecasts

Reality check: Unpacking the $150B GLP-1 market forecasts

Jun 11, 2025  0

Weeks after TIGIT fail, iTeos decides to wind down

Weeks after TIGIT fail, iTeos decides to wind down

May 28, 2025  0